| scholarly article | Q13442814 |
| P2093 | author name string | Osuka S | |
| Van Meir EG | |||
| P2860 | cites work | Genome-wide association study of glioma and meta-analysis | Q23919638 |
| Temozolomide for high grade glioma | Q24197645 | ||
| FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis | Q24293807 | ||
| PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas | Q24615768 | ||
| Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma | Q24632791 | ||
| Safety, activity, and immune correlates of anti-PD-1 antibody in cancer | Q24633070 | ||
| Direct inhibition of the NOTCH transcription factor complex | Q24634015 | ||
| An integrated genomic analysis of human glioblastoma multiforme | Q24648860 | ||
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance | Q26765869 | ||
| Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date | Q26822717 | ||
| Brain tumor stem cells: Molecular characteristics and their impact on therapy | Q27003138 | ||
| Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules | Q37581947 | ||
| In vivo radiation response of proneural glioma characterized by protective p53 transcriptional program and proneural-mesenchymal shift. | Q37702083 | ||
| Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? | Q38062793 | ||
| Hypoxia inducible factor pathway inhibitors as anticancer therapeutics. | Q38097867 | ||
| The role of cytoreductive surgery in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline. | Q38206395 | ||
| Detoxification of oxidative stress in glioma stem cells: mechanism, clinical relevance, and therapeutic development | Q38231884 | ||
| Molecularly targeted therapies for recurrent glioblastoma: current and future targets | Q38272728 | ||
| BMI1 sustains human glioblastoma multiforme stem cell renewal | Q38352238 | ||
| Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma | Q38453759 | ||
| Radiation resistance: Cancer stem cells (CSCs) and their enigmatic pro-survival signaling | Q38590765 | ||
| NADP(+)-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance | Q38818325 | ||
| Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. | Q38955683 | ||
| Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells | Q39004963 | ||
| Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy | Q39017301 | ||
| Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP. | Q39290679 | ||
| Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis. | Q39303842 | ||
| Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway | Q39337251 | ||
| Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells. | Q39653276 | ||
| BMI1 Confers Radioresistance to Normal and Cancerous Neural Stem Cells through Recruitment of the DNA Damage Response Machinery | Q39674232 | ||
| Clonal evolution of glioblastoma under therapy. | Q39704836 | ||
| Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents | Q27777800 | ||
| Nivolumab plus ipilimumab in advanced melanoma | Q27852310 | ||
| Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency. | Q27853362 | ||
| Glioma stem cells promote radioresistance by preferential activation of the DNA damage response | Q27860541 | ||
| Identification of human brain tumour initiating cells | Q27860921 | ||
| Improved Survival with Ipilimumab in Patients with Metastatic Melanoma | Q27861062 | ||
| Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner. | Q28115436 | ||
| Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells | Q28176681 | ||
| Cancer immunoediting: from immunosurveillance to tumor escape | Q28212251 | ||
| Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma | Q28236409 | ||
| The clonal evolution of tumor cell populations | Q28271546 | ||
| Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma | Q28287898 | ||
| The somatic genomic landscape of glioblastoma | Q28300185 | ||
| TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma | Q28300871 | ||
| Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier | Q28550363 | ||
| IDH mutation impairs histone demethylation and results in a block to cell differentiation | Q29305058 | ||
| The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers | Q29395525 | ||
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations | Q29614275 | ||
| A perivascular niche for brain tumor stem cells | Q29614276 | ||
| Genome-wide association study identifies five susceptibility loci for glioma | Q29614921 | ||
| Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma | Q29615604 | ||
| A restricted cell population propagates glioblastoma growth after chemotherapy | Q29615605 | ||
| Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies | Q29615606 | ||
| Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma | Q29615607 | ||
| Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor | Q29617062 | ||
| Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177. | Q30437778 | ||
| Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma | Q30847783 | ||
| Digital Pathology: Data-Intensive Frontier in Medical Imaging: Health-information sharing, specifically of digital pathology, is the subject of this paper which discusses how sharing the rich images in pathology can stretch the capabilities of all o | Q30862582 | ||
| Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro. | Q33378368 | ||
| c-Myc is required for maintenance of glioma cancer stem cells | Q33385645 | ||
| p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation | Q33733341 | ||
| Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell Maintenance | Q34006181 | ||
| Human Brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma | Q34052754 | ||
| NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. | Q34085883 | ||
| A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma | Q34228481 | ||
| Wnt activation is implicated in glioblastoma radioresistance | Q34232635 | ||
| miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells | Q36568466 | ||
| Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. | Q36673354 | ||
| Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice | Q36677747 | ||
| Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. | Q36884210 | ||
| Drosophila Brat and Human Ortholog TRIM3 Maintain Stem Cell Equilibrium and Suppress Brain Tumorigenesis by Attenuating Notch Nuclear Transport | Q36918095 | ||
| Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery | Q36925174 | ||
| Punctuated evolution of prostate cancer genomes | Q36950514 | ||
| Anti-apoptosis mechanisms in malignant gliomas. | Q37059590 | ||
| Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells | Q37221453 | ||
| Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial | Q37240846 | ||
| Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. | Q37279893 | ||
| Tumor initiating cells in malignant gliomas: biology and implications for therapy | Q37384328 | ||
| High levels of Id1 expression define B1 type adult neural stem cells | Q37417845 | ||
| Active medulloblastoma enhancers reveal subgroup-specific cellular origins | Q37517791 | ||
| Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin | Q39741500 | ||
| Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial. | Q39786861 | ||
| Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution | Q39872681 | ||
| Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal | Q39916475 | ||
| Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. | Q40179252 | ||
| Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis | Q40303940 | ||
| Inhibition of EGFR induces a c-MET-driven stem cell population in glioblastoma | Q41017478 | ||
| Mutational landscape and clonal architecture in grade II and III gliomas | Q41107185 | ||
| Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. | Q41128352 | ||
| Brain tumor-polyposis syndrome: two genetic diseases? | Q41524783 | ||
| Rapid Reprogramming of Primary Human Astrocytes into Potent Tumor-Initiating Cells with Defined Genetic Factors | Q41594903 | ||
| The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. | Q41736480 | ||
| Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model. | Q41853906 | ||
| PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells | Q42148487 | ||
| The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development | Q42492007 | ||
| Targeting cancer stem cells through L1CAM suppresses glioma growth | Q42547900 | ||
| Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes | Q42934875 | ||
| Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme | Q43011801 | ||
| Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model | Q43170042 | ||
| Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. | Q43246655 | ||
| Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. | Q43283510 | ||
| The law of Bergonié and Tribondeau: a nice formula for a first approximation. | Q43806322 | ||
| Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion. | Q43998995 | ||
| EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. | Q44200074 | ||
| Hypoxia and oxygenation induce a metabolic switch between pentose phosphate pathway and glycolysis in glioma stem-like cells. | Q44391299 | ||
| IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells | Q44536385 | ||
| Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors | Q45205107 | ||
| The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. | Q46016867 | ||
| The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. | Q46021705 | ||
| An extent of resection threshold for newly diagnosed glioblastomas | Q46126935 | ||
| Characterizing invading glioma cells based on IDH1-R132H and Ki-67 immunofluorescence. | Q46184998 | ||
| A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM). | Q46239069 | ||
| MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients | Q46619783 | ||
| A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma | Q48052209 | ||
| CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles | Q48177168 | ||
| A hierarchy of self-renewing tumor-initiating cell types in glioblastoma | Q48239341 | ||
| Accumulation of CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation | Q48282684 | ||
| Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma | Q48329991 | ||
| Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies. | Q48494960 | ||
| MET signaling regulates glioblastoma stem cells. | Q48498498 | ||
| Contiguous glioblastoma multiforme and fibrosarcoma with extracranial metastasis. | Q49009174 | ||
| Oncolytic viruses targeting tumor stem cells. | Q51846243 | ||
| Brain tumour cells interconnect to a functional and resistant network. | Q52147171 | ||
| A novel stem cell culture model of recurrent glioblastoma. | Q52147578 | ||
| Spatiotemporal Evolution of the Primary Glioblastoma Genome. | Q52149231 | ||
| Mutational context and diverse clonal development in early and late bladder cancer. | Q53144252 | ||
| Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. | Q53201476 | ||
| Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor. | Q55476499 | ||
| Chromosome and chromosomal progression of human gliomas in vivo, in vitro and in athymic nude mice. | Q55489038 | ||
| Epidermal growth factor receptor and Ink4a/Arf | Q57277079 | ||
| Notch promotes radioresistance of glioma stem cells | Q84921228 | ||
| Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma | Q34391844 | ||
| CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. | Q34449062 | ||
| Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth | Q34457728 | ||
| Brain tumor cells in circulation are enriched for mesenchymal gene expression | Q34458631 | ||
| Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma | Q34488771 | ||
| Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer | Q34500359 | ||
| Insulator dysfunction and oncogene activation in IDH mutant gliomas | Q34506441 | ||
| Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells | Q34588662 | ||
| Glioma cancer stem cells induce immunosuppressive macrophages/microglia | Q34992518 | ||
| Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity | Q35031305 | ||
| c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. | Q35049178 | ||
| Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution | Q35157212 | ||
| Metabolic state of glioma stem cells and nontumorigenic cells | Q35229102 | ||
| Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells | Q35238052 | ||
| The evolutionary history of lethal metastatic prostate cancer | Q35548366 | ||
| The PD-1/B7-H1 pathway modulates the natural killer cells versus mouse glioma stem cells | Q35743681 | ||
| HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity | Q35757997 | ||
| Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response | Q35779256 | ||
| Asymmetry-defective oligodendrocyte progenitors are glioma precursors | Q35814886 | ||
| Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma | Q35815273 | ||
| Cancer stem cells in glioblastoma | Q35829972 | ||
| Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein | Q35842160 | ||
| Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells | Q35879903 | ||
| Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy | Q35929463 | ||
| Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation | Q35931312 | ||
| Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype | Q36015831 | ||
| DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors | Q36069167 | ||
| STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and Transformation | Q36130808 | ||
| Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer | Q36144913 | ||
| Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes | Q36168176 | ||
| MicroRNA-153/Nrf-2/GPx1 pathway regulates radiosensitivity and stemness of glioma stem cells via reactive oxygen species | Q36355853 | ||
| Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4 | Q36488714 | ||
| Mechanisms of immune evasion by tumors | Q36490750 | ||
| Standards of care for treatment of recurrent glioblastoma--are we there yet? | Q36500401 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 415-426 | |
| P577 | publication date | 2017-02-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Overcoming therapeutic resistance in glioblastoma: the way forward | |
| P478 | volume | 127 |
| Q90610195 | 18F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling |
| Q51746123 | A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells. |
| Q90334993 | A Novel Multi-Target Small Molecule, LCC-09, Inhibits Stemness and Therapy-Resistant Phenotypes of Glioblastoma Cells by Increasing miR-34a and Deregulating the DRD4/Akt/mTOR Signaling Axis |
| Q91405079 | A new model isolates glioblastoma clonal interactions and reveals unexpected modes for regulating motility, proliferation, and drug resistance |
| Q53692403 | ATR kinase inhibitors NVP-BEZ235 and AZD6738 effectively penetrate the brain after systemic administration. |
| Q90481845 | ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma |
| Q55457493 | Adoptive Transfer of IL13Rα2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma. |
| Q57291651 | An orthotopic glioblastoma animal model suitable for high-throughput screenings |
| Q60311013 | Association between autocrine motility factor receptor gene polymorphism (rs2440472, rs373191257) and glioblastoma multiform in a representative Iranian population |
| Q90354120 | Asunercept as an innovative therapeutic approach for recurrent glioblastoma and other malignancies |
| Q55010335 | CDK5 Inhibition Resolves PKA/cAMP-Independent Activation of CREB1 Signaling in Glioma Stem Cells. |
| Q93133542 | CDK5-dependent phosphorylation and nuclear translocation of TRIM59 promotes macroH2A1 ubiquitination and tumorigenicity |
| Q88391205 | Cancer therapy: Neutrophils traffic in cancer nanodrugs |
| Q93260313 | Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma |
| Q58751776 | Casein Kinase 1 Epsilon Regulates Glioblastoma Cell Survival |
| Q89820892 | Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches |
| Q91984594 | Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma |
| Q90481791 | Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment via nanotechnology |
| Q55457104 | Concomitant administration of radiation with eribulin improves the survival of mice harboring intracerebral glioblastoma. |
| Q92857557 | Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study |
| Q64067528 | Deregulated MicroRNA Signature Following Glioblastoma Irradiation |
| Q64271846 | Embryonic Stem Cells-Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy |
| Q92032316 | Enterovirus A71 Oncolysis of Malignant Gliomas |
| Q50000466 | Evaluation of chemical chaperones based on the monitoring of Bip promoter activity and visualization of extracellular vesicles by real-time bioluminescence imaging. |
| Q58705906 | Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1] |
| Q98178394 | Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression |
| Q40070708 | Gene Therapy in the Nervous System: Failures and Successes. |
| Q55456789 | Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma. |
| Q90734706 | Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets |
| Q92043370 | Glioblastoma cells vampirize WNT from neurons and trigger a JNK/MMP signaling loop that enhances glioblastoma progression and neurodegeneration |
| Q50061542 | Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium. |
| Q58606197 | Glioma cell proliferation is enhanced in the presence of tumor-derived cilia vesicles |
| Q55180455 | Hyperbaric oxygen therapy as adjunctive strategy in treatment of glioblastoma multiforme. |
| Q90012407 | IGFBP5 increases cell invasion and inhibits cell proliferation by EMT and Akt signaling pathway in Glioblastoma multiforme cells |
| Q58573449 | Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma |
| Q97069628 | Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities |
| Q64101467 | Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma |
| Q89950790 | Intracranial glioma xenograft model rapidly reestablishes blood-brain barrier integrity for longitudinal imaging of tumor progression using fluorescence molecular tomography and contrast agents |
| Q38838354 | Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma |
| Q91774056 | Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux |
| Q91990394 | Lessons Learned in Using Laser Interstitial Thermal Therapy (LITT) for Treatment of Brain Tumors: A Case Series of 238 Patients from A Single Institution |
| Q99551048 | Linc-RA1 inhibits autophagy and promotes radioresistance by preventing H2Bub1/USP44 combination in glioma cells |
| Q89841896 | Lipid Peroxidation Plays an Important Role in Chemotherapeutic Effects of Temozolomide and the Development of Therapy Resistance in Human Glioblastoma |
| Q47161790 | MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma. |
| Q96127081 | Measuring Cancer Hallmark Mediation of the TET1 Glioma Survival Effect with Linked Neural-Network Based Mediation Experiments |
| Q48269310 | Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In Vivo. |
| Q55663256 | Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance. |
| Q57479673 | Myt1 and Myt1l transcription factors limit proliferation in GBM cells by repressing YAP1 expression |
| Q92644673 | Nanocarrier-based drug combination therapy for glioblastoma |
| Q96128057 | Olig2 SUMOylation protects against genotoxic damage response by antagonizing p53 gene targeting |
| Q102059097 | PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III |
| Q90721346 | PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas |
| Q57461781 | PHF19 promotes the proliferation, migration, and chemosensitivity of glioblastoma to doxorubicin through modulation of the SIAH1/β-catenin axis |
| Q64227275 | Paeoniflorin Inhibits Hepatocyte Growth Factor- (HGF-) Induced Migration and Invasion and Actin Rearrangement via Suppression of c-Met-Mediated RhoA/ROCK Signaling in Glioblastoma |
| Q55178723 | Paeoniflorin inhibits glioblastoma growth in vivo and in vitro: a role for the Triad3A-dependent ubiquitin proteasome pathway in TLR4 degradation. |
| Q47891219 | Pro-necrotic Activity of Cationic Mastoparan Peptides in Human Glioblastoma Multiforme Cells Via Membranolytic Action. |
| Q89622421 | Publication Landscape Analysis on Gliomas: How Much Has Been Done in the Past 25 Years? |
| Q91711337 | Radiation-Induced Changes in Tumor Vessels and Microenvironment Contribute to Therapeutic Resistance in Glioblastoma |
| Q64386954 | Radiation-induced DNA damage cooperates with heterozygosity of TP53 and PTEN to generate high grade gliomas |
| Q94495177 | Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas |
| Q64068359 | Radiosensitization of orthotopic GIC-driven glioblastoma by doxycycline causes skin damage |
| Q92607047 | Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma |
| Q44888065 | Review of Natural Product-Derived Compounds as Potent Antiglioblastoma Drugs |
| Q92963775 | SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes |
| Q64274365 | Semaphorin 3C as a Therapeutic Target in Prostate and Other Cancers |
| Q64376724 | Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection |
| Q92153802 | Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors |
| Q90625397 | TGF-β-activated lncRNA LINC00115 is a critical regulator of glioma stem-like cell tumorigenicity |
| Q47828321 | TRIM59 promotes gliomagenesis by inhibiting TC45 dephosphorylation of STAT3. |
| Q89053707 | Targeting of BMI-1 with PTC-209 inhibits glioblastoma development |
| Q89088558 | The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance |
| Q92004811 | Treatment Strategies Based on Histological Targets against Invasive and Resistant Glioblastoma |
Search more.